Header Logo

LAURA BOVER

TitleAssociate Professor
InstitutionMD Anderson
DepartmentGenomic Medicine
Address1901 East Road
Houston TX 77054-3005
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Willoughby JE, Dou L, Bhattacharya S, Jackson H, Seestaller-Wehr L, Kilian D, Bover L, Voo KS, Cox KL, Murray T, John M, Shi H, Bojczuk P, Jing J, Niederer H, Shepherd AJ, Hook L, Hopley S, Inzhelevskaya T, Penfold CA, Mockridge CI, English V, Brett SJ, Srinivasan R, Hopson C, Smothers J, Hoos A, Paul E, Martin SL, Morley PJ, Yanamandra N, Cragg MS. Impact of isotype on the mechanism of action of agonist anti-OX40 antibodies in cancer: implications for therapeutic combinations. J Immunother Cancer. 2024 Jul 04; 12(7). PMID: 38964788; PMCID: PMC11227834.
      Citations:    Fields:    Translation:HumansAnimalsCells
    2. Li Y, Basar R, Wang G, Liu E, Moyes JS, Li L, Kerbauy LN, Uprety N, Fathi M, Rezvan A, Banerjee PP, Muniz-Feliciano L, Laskowski TJ, Ensley E, Daher M, Shanley M, Mendt M, Acharya S, Liu B, Biederst?dt A, Rafei H, Guo X, Melo Garcia L, Lin P, Ang S, Marin D, Chen K, Bover L, Champlin RE, Varadarajan N, Shpall EJ, Rezvani K. Author Correction: KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape. Nat Med. 2024 Mar; 30(3):906. PMID: 38182787.
      Citations:    Fields:    
    3. Chu F, Cao J, Liu J, Yang H, Davis TJ, Kuang SQ, Cheng X, Zhang Z, Karri S, Vien LT, Bover L, Sun R, Vega F, Green M, Davis RE, Neelapu SS. Chimeric antigen receptor T cells to target CD79b in B-cell lymphomas. J Immunother Cancer. 2023 11 24; 11(11). PMID: 38007239; PMCID: PMC10680003.
      Citations:    Fields:    Translation:HumansCells
    4. Li Y, Basar R, Wang G, Liu E, Moyes JS, Li L, Kerbauy LN, Uprety N, Fathi M, Rezvan A, Banerjee PP, Muniz-Feliciano L, Laskowski TJ, Ensley E, Daher M, Shanley M, Mendt M, Acharya S, Liu B, Biederst?dt A, Rafei H, Guo X, Melo Garcia L, Lin P, Ang S, Marin D, Chen K, Bover L, Champlin RE, Varadarajan N, Shpall EJ, Rezvani K. KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape. Nat Med. 2022 Oct; 28(10):2133-2144. PMID: 36175679; PMCID: PMC9942695.
      Citations: 16     Fields:    Translation:Cells
    5. Khadka S, Vien L, Leonard P, Bover L, Muller F. Generation and Validation of an Anti-Human PANK3 Mouse Monoclonal Antibody. Biomolecules. 2022 09 19; 12(9). PMID: 36139163; PMCID: PMC9496473.
      Citations:    
    6. Singh S, Roszik J, Saini N, Singh VK, Bavisi K, Wang Z, Vien LT, Yang Z, Kundu S, Davis RE, Bover L, Diab A, Neelapu SS, Overwijk WW, Rai K, Singh M. B Cells Are Required to Generate Optimal Anti-Melanoma Immunity in Response to Checkpoint Blockade. Front Immunol. 2022; 13:794684. PMID: 35720386; PMCID: PMC9204262.
      Citations:    Fields:    Translation:HumansAnimalsCells
    7. Yang R, Sun L, Li CF, Wang YH, Xia W, Liu B, Chu YY, Bover L, Vien L, Hung MC. Development and characterization of anti-galectin-9 antibodies that protect T cells from galectin-9-induced cell death. J Biol Chem. 2022 04; 298(4):101821. PMID: 35283189; PMCID: PMC9006662.
      Citations:    Fields:    Translation:HumansCells
    8. Muhsin A, Rangel R, Vien L, Bover L. Monoclonal Antibodies Generation: Updates and Protocols on Hybridoma Technology. Methods Mol Biol. 2022; 2435:73-93. PMID: 34993940.
      Citations:    Fields:    Translation:AnimalsCells
    9. Wilson NR, Bover L, Konopleva M, Han L, Neelapu S, Pemmaraju N. CD303 (BDCA-2) - a potential novel target for therapy in hematologic malignancies. Leuk Lymphoma. 2022 01; 63(1):19-30. PMID: 34486917.
      Citations: 1     Fields:    Translation:HumansCells
    10. McAllister F, Mantegazza A, Bover L, Garz?n F, Rotbaum V, Remondino G, Vazquez Larsson M, Geffner J, Rabinovich GA. [Use of convalescent plasma for COVID-19 treatment. History and evidence]. Medicina (B Aires). 2020; 80 Suppl 3:82-86. PMID: 32658853.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    11. Yeung TL, Leung CS, Yip KP, Sheng J, Vien L, Bover LC, Birrer MJ, Wong STC, Mok SC. Anticancer Immunotherapy by MFAP5 Blockade Inhibits Fibrosis and Enhances Chemosensitivity in Ovarian and Pancreatic Cancer. Clin Cancer Res. 2019 11 01; 25(21):6417-6428. PMID: 31332047; PMCID: PMC6825539.
      Citations: 17     Fields:    Translation:HumansAnimalsCells
    12. Bi E, Li R, Bover LC, Li H, Su P, Ma X, Huang C, Wang Q, Liu L, Yang M, Lin Z, Qian J, Fu W, Liu YJ, Yi Q. E-cadherin expression on multiple myeloma cells activates tumor-promoting properties in plasmacytoid DCs. J Clin Invest. 2018 11 01; 128(11):4821-4831. PMID: 30277474; PMCID: PMC6205396.
      Citations: 17     Fields:    Translation:HumansAnimalsCells
    13. Qin H, Wei G, Sakamaki I, Dong Z, Cheng WA, Smith DL, Wen F, Sun H, Kim K, Cha S, Bover L, Neelapu SS, Kwak LW. Novel BAFF-Receptor Antibody to Natively Folded Recombinant Protein Eliminates Drug-Resistant Human B-cell Malignancies In Vivo. Clin Cancer Res. 2018 03 01; 24(5):1114-1123. PMID: 29180606; PMCID: PMC8953840.
      Citations: 15     Fields:    Translation:HumansAnimalsCells
    14. Jiang H, Rivera-Molina Y, Gomez-Manzano C, Clise-Dwyer K, Bover L, Vence LM, Yuan Y, Lang FF, Toniatti C, Hossain MB, Fueyo J. Oncolytic Adenovirus and Tumor-Targeting Immune Modulatory Therapy Improve Autologous Cancer Vaccination. Cancer Res. 2017 07 15; 77(14):3894-3907. PMID: 28566332; PMCID: PMC5549681.
      Citations: 74     Fields:    Translation:HumansAnimalsCells
    15. Puebla-Osorio N, Damiani E, Bover L, Ullrich SE. Platelet-activating factor induces cell cycle arrest and disrupts the DNA damage response in mast cells. Cell Death Dis. 2015 May 07; 6:e1745. PMID: 25950475; PMCID: PMC4669695.
      Citations: 7     Fields:    Translation:HumansCells
    16. Karjalainen K, Jaalouk DE, Bueso-Ramos C, Bover L, Sun Y, Kuniyasu A, Driessen WH, Rietz C, Zurita AJ, O'Brien S, Kantarjian HM, Cortes JE, Calin GA, Koivunen E, Arap W, Pasqualini R, Card?-Vila M. Targeting IL11 Receptor in Leukemia and Lymphoma: A Functional Ligand-Directed Study and Hematopathology Analysis of Patient-Derived Specimens. Clin Cancer Res. 2015 Jul 01; 21(13):3041-51. PMID: 25779950; PMCID: PMC4490100.
      Citations: 4     Fields:    Translation:HumansCells
    17. Arumugam T, Deng D, Bover L, Wang H, Logsdon CD, Ramachandran V. New Blocking Antibodies against Novel AGR2-C4.4A Pathway Reduce Growth and Metastasis of Pancreatic Tumors and Increase Survival in Mice. Mol Cancer Ther. 2015 Apr; 14(4):941-51. PMID: 25646014; PMCID: PMC4710371.
      Citations: 25     Fields:    Translation:HumansAnimalsCells
    18. Voo KS, Bover L, Harline ML, Weng J, Sugimoto N, Liu YJ. Targeting of TLRs inhibits CD4+ regulatory T cell function and activates lymphocytes in human peripheral blood mononuclear cells. J Immunol. 2014 Jul 15; 193(2):627-34. PMID: 24928999; PMCID: PMC4347808.
      Citations: 18     Fields:    Translation:HumansCells
    19. Voo KS, Foglietta M, Percivalle E, Chu F, Nattamai D, Harline M, Lee ST, Bover L, Lin HY, Baladandayuthapani V, Delgado D, Luong A, Davis RE, Kwak LW, Liu YJ, Neelapu SS. Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma. Int J Cancer. 2014 Dec 15; 135(12):2834-46. PMID: 24771328; PMCID: PMC4352105.
      Citations: 13     Fields:    Translation:HumansCells
    20. Hu J, Vien LT, Xia X, Bover L, Li S. Generation of a monoclonal antibody against the glycosylphosphatidylinositol-linked protein Rae-1 using genetically engineered tumor cells. Biol Proced Online. 2014 Feb 04; 16(1):3. PMID: 24495546; PMCID: PMC3916315.
      Citations: 5     
    21. Voo KS, Bover L, Harline ML, Vien LT, Facchinetti V, Arima K, Kwak LW, Liu YJ. Antibodies targeting human OX40 expand effector T cells and block inducible and natural regulatory T cell function. J Immunol. 2013 Oct 01; 191(7):3641-50. PMID: 24014877; PMCID: PMC3812678.
      Citations: 42     Fields:    Translation:HumansAnimalsCells
    22. Bao M, Hanabuchi S, Facchinetti V, Du Q, Bover L, Plumas J, Chaperot L, Cao W, Qin J, Sun SC, Liu YJ. CD2AP/SHIP1 complex positively regulates plasmacytoid dendritic cell receptor signaling by inhibiting the E3 ubiquitin ligase Cbl. J Immunol. 2012 Jul 15; 189(2):786-92. PMID: 22706086; PMCID: PMC3665352.
      Citations: 25     Fields:    Translation:HumansCells
    23. Talukder AH, Bao M, Kim TW, Facchinetti V, Hanabuchi S, Bover L, Zal T, Liu YJ. Phospholipid scramblase 1 regulates Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells. Cell Res. 2012 Jul; 22(7):1129-39. PMID: 22453241; PMCID: PMC3391020.
      Citations: 26     Fields:    Translation:HumansAnimalsCells
    24. Pedroza-Gonzalez A, Xu K, Wu TC, Aspord C, Tindle S, Marches F, Gallegos M, Burton EC, Savino D, Hori T, Tanaka Y, Zurawski S, Zurawski G, Bover L, Liu YJ, Banchereau J, Palucka AK. Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation. J Exp Med. 2011 Mar 14; 208(3):479-90. PMID: 21339324; PMCID: PMC3058586.
      Citations: 117     Fields:    Translation:HumansAnimalsCells
    25. Kim T, Pazhoor S, Bao M, Zhang Z, Hanabuchi S, Facchinetti V, Bover L, Plumas J, Chaperot L, Qin J, Liu YJ. Aspartate-glutamate-alanine-histidine box motif (DEAH)/RNA helicase A helicases sense microbial DNA in human plasmacytoid dendritic cells. Proc Natl Acad Sci U S A. 2010 Aug 24; 107(34):15181-6. PMID: 20696886; PMCID: PMC2930588.
      Citations: 171     Fields:    Translation:HumansCells
    26. Cao W, Bover L. Signaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cells. Immunol Rev. 2010 Mar; 234(1):163-76. PMID: 20193018; PMCID: PMC2919054.
      Citations: 29     Fields:    Translation:HumansAnimalsCells
    27. Cao W, Bover L, Cho M, Wen X, Hanabuchi S, Bao M, Rosen DB, Wang YH, Shaw JL, Du Q, Li C, Arai N, Yao Z, Lanier LL, Liu YJ. Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction. J Exp Med. 2009 Jul 06; 206(7):1603-14. PMID: 19564354; PMCID: PMC2715090.
      Citations: 164     Fields:    Translation:HumansAnimalsCells
    28. Voo KS, Wang YH, Santori FR, Boggiano C, Wang YH, Arima K, Bover L, Hanabuchi S, Khalili J, Marinova E, Zheng B, Littman DR, Liu YJ. Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc Natl Acad Sci U S A. 2009 Mar 24; 106(12):4793-8. PMID: 19273860; PMCID: PMC2653560.
      Citations: 304     Fields:    Translation:HumansCells
    29. Ito T, Hanabuchi S, Wang YH, Park WR, Arima K, Bover L, Qin FX, Gilliet M, Liu YJ. Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity. 2008 Jun; 28(6):870-80. PMID: 18513999; PMCID: PMC2709453.
      Citations: 218     Fields:    Translation:HumansCells
    30. Cao W, Zhang L, Rosen DB, Bover L, Watanabe G, Bao M, Lanier LL, Liu YJ. BDCA2/Fc epsilon RI gamma complex signals through a novel BCR-like pathway in human plasmacytoid dendritic cells. PLoS Biol. 2007 Sep 11; 5(10):e248. PMID: 17850179; PMCID: PMC1971124.
      Citations: 72     Fields:    Translation:HumansAnimalsCells
    31. Bover LC, Kuniyasu A, Sun J, Rangel R, Takeya M, Aggarwal BB, Arap W, Pasqualini R, Card?-Vila M. A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications. J Immunol. 2007 Jun 15; 178(12):8183-94. PMID: 17548657.
      Citations: 92     Fields:    Translation:HumansAnimalsCells
    32. Cao W, Rosen DB, Ito T, Bover L, Bao M, Watanabe G, Yao Z, Zhang L, Lanier LL, Liu YJ. Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production. J Exp Med. 2006 Jun 12; 203(6):1399-405. PMID: 16735691; PMCID: PMC2118323.
      Citations: 118     Fields:    Translation:HumansCells
    33. Kolonin MG, Bover L, Sun J, Zurita AJ, Do KA, Lahdenranta J, Giordano RJ, Jaalouk DE, Ozawa MG, Moya CA, Souza GR, Staquicini FI, Kunyiasu A, Scudiero DA, Holbeck SL, Sausville EA, Arap W, Pasqualini R, Card?-Vila M. Ligand-directed surface profiling of human cancer cells with combinatorial peptide libraries. Cancer Res. 2006 Jan 01; 66(1):34-40. PMID: 16397212.
      Citations: 35     Fields:    Translation:HumansCells
    34. Moutel S, Bover L, Weck M, Brossart P, Teillaud JL, Mantegazza AR, Barrio MM, Mordoh J. CD63 tetraspanin slows down cell migration and translocates to the endosomal-lysosomal-MIICs route after extracellular stimuli in human immature dendritic cells. Blood. 2004 Aug 15; 104(4):1183-90. PMID: 15130945.
      Citations: 49     Fields:    Translation:HumansCells
    35. Bover L, Portela P, Mordoh J, Capurro M, Ballar? C. Differential lytic and agglutinating activity of the anti-Lewis(x) monoclonal antibody FC-2.15 on human polymorphonuclear neutrophils and MCF-7 breast tumor cells. In vitro and ex vivo studies. Cancer Immunol Immunother. 1999 May-Jun; 48(2-3):100-8. PMID: 10414463; PMCID: PMC11037171.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    36. Barrio M, Bravo AI, Slavutsky I, Larripa I, Bolondi A, Ayala M, Mordoh J, Bover L. The human breast cancer cell line IIB-BR-G has amplified c-myc and c-fos oncogenes in vitro and is spontaneously metastatic in vivo. Cell Mol Biol (Noisy-le-grand). 1998 May; 44(3):493-504. PMID: 9620446.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    37. Bover L, Portela P, Livingston P, Mordoh J, Capurro M. FC-2.15, a monoclonal antibody active against human breast cancer, specifically recognizes Lewis(x) hapten. Cancer Immunol Immunother. 1998 Feb; 45(6):334-9. PMID: 9490204; PMCID: PMC11037837.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    38. Ledda F, Bravo AI, Adris S, Bover L, Mordoh J, Podhajcer OL. The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma. J Invest Dermatol. 1997 Feb; 108(2):210-4. PMID: 9008236.
      Citations: 43     Fields:    Translation:HumansCells
    39. Ledda MF, Adris S, Bravo AI, Kairiyama C, Bover L, Chernajovsky Y, Mordoh J, Podhajcer OL. Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells. Nat Med. 1997 Feb; 3(2):171-6. PMID: 9018235.
      Citations: 64     Fields:    Translation:HumansAnimalsCells
    40. Kairiyama C, Bover L, Solarolo E, Mordoh J. Allogeneic cells vaccine increases disease-free survival in stage III melanoma patients. A non randomized phase II study. Medicina (B Aires). 1997; 57(4):421-7. PMID: 9674264.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    41. Adris S, Bravo AI, Bover L, Carbone C, Paleolog E, Mordoh J, Chernajovsky Y, Podhajcer OL, Ledda MF. Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell model. Cell Mol Biol (Noisy-le-grand). 1996 Jul; 42(5):769-78. PMID: 8832108.
      Citations:    Fields:    Translation:AnimalsCells
    42. Bover L, Mordoh J, Morvillo V. Identification and characterization of a 14 kDa immunosuppressive protein derived from IIB-MEL-J, a human melanoma cell line. Cell Mol Biol (Noisy-le-grand). 1996 Jul; 42(5):779-95. PMID: 8832109.
      Citations:    Fields:    Translation:HumansCells
    43. Adris S, Bover L, Bravo AL, Mordoh J, Podhajcer OL, Ledda MF. [The role of SPARC gene in tumorigenic capacity of human melanoma cells]. Medicina (B Aires). 1996; 56(1):51-4. PMID: 8734932.
      Citations:    Fields:    Translation:HumansAnimalsCells
    44. Kairiyama C, Slavutsky I, Larripa I, Morvillo V, Bravo AI, Bover L, Podhajcer OL, Mordoh J. Biologic, immunocytochemical, and cytogenetic characterization of two new human melanoma cell lines: IIB-MEL-LES and IIB-MEL-IAN. Pigment Cell Res. 1995 Jun; 8(3):121-31. PMID: 7567787.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    45. Bover L, Bravo AI, Ledda MF, Kairiyama C, Calb I, Guerra L, Capony F, Mordoh J, Podhajcer OL. Expression of cathepsin D in primary and metastatic human melanoma and dysplastic nevi. J Invest Dermatol. 1995 Mar; 104(3):340-4. PMID: 7860998.
      Citations: 14     Fields:    Translation:HumansCells
    46. Mordoh J, Leis S, Bravo AI, Podhajcer OL, Ballare C, Capurro M, Kairiyama C, Bover L. Description of a new monoclonal antibody, FC-2.15, reactive with human breast cancer and other human neoplasias. Int J Biol Markers. 1994 Jul-Sep; 9(3):125-34. PMID: 7829891.
      Citations: 3     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    47. Bover L, Barrio M, Slavutsky I, Bravo AI, Quintans C, Bagnati A, Lema B, Schiaffi J, Yomha R, Mordoh J. Description of a new human breast cancer cell line, IIB-BR-G, established from a primary undifferentiated tumor. Breast Cancer Res Treat. 1991 Sep; 19(1):47-56. PMID: 1661624.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    48. Guerra L, Bover L, Mordoh J. Differentiating effect of L-tyrosine on the human melanoma cell line IIB-MEL-J. Exp Cell Res. 1990 May; 188(1):61-5. PMID: 2328778.
      Citations: 2     Fields:    Translation:HumansCells
    49. Medrano EE, Resnicoff M, Cafferata EG, Larcher F, Podhajcer O, Bover L, Molinari B. Increased secretory activity and estradiol receptor expression are among other relevant aspects of MCF-7 human breast tumor cell growth which are expressed only in the absence of serum. Exp Cell Res. 1990 May; 188(1):2-9. PMID: 2184046.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    50. Resnicoff M, Bover L, Medrano EE, Slavutsky I, Larripa I, Mordoh J, Podhajcer OL. Effect of estradiol and tamoxifen on the anchorage-independent growth of the subpopulations derived from MCF-7 breast carcinoma cells: cytogenetic analysis of the stem cell subpopulation. Exp Cell Res. 1988 Nov; 179(1):58-64. PMID: 3169151.
      Citations:    Fields:    Translation:HumansCells
    51. Podhajcer OL, Bravo AI, Dain L, Guman N, Bover L, Mordoh J. In vitro analysis of the cellular proliferative response to 17-beta-estradiol of human breast cancer. Cancer. 1988 May 01; 61(9):1807-12. PMID: 3281743.
      Citations: 2     Fields:    Translation:HumansCells
    52. Resnicoff M, Medrano EE, Podhajcer OL, Bravo AI, Bover L, Mordoh J. Subpopulations of MCF7 cells separated by Percoll gradient centrifugation: a model to analyze the heterogeneity of human breast cancer. Proc Natl Acad Sci U S A. 1987 Oct; 84(20):7295-9. PMID: 2823256; PMCID: PMC299279.
      Citations: 29     Fields:    Translation:HumansCells
    53. Cabral S, Leis S, Bover L, Nembrot M, Mordoh J. Dipyridamole inhibits reversion by thymidine of methotrexate effect and increases drug uptake in Sarcoma 180 cells. Proc Natl Acad Sci U S A. 1984 May; 81(10):3200-3. PMID: 6587345; PMCID: PMC345249.
      Citations: 11     Fields:    Translation:AnimalsCells
    54. Platelet-activating factor induces cell cycle arrest and disrupts the DNA damage response in mast cells. Cell Death and Disease. 6.
    55. Tumor imaging with 99mTc-labeled FC-5.01 monoclonal antibody using a single step labeling method. Journal of Radioanalytical and Nuclear Chemistry. 245:337-341.
    56. Biological aspects of human plasmacytoid dendritic cells and their leukemic counterparts; similarities and differences. Inmunologia. 29:125-134.
    57. New blocking antibodies against novel AGR2-C4.4A pathway reduce growth and metastasis of pancreatic tumors and increase survival in mice. Molecular Cancer Therapeutics. 14:941-951.
    58. Targeting IL11 receptor in leukemia and lymphoma. Clinical Cancer Research. 21:3041-3051.
    59. Analysis of DNA synthesis and carcinoembryonic antigen expression in human breast cancer. Journal of Experimental and Clinical Cancer Research. 7:35-42.
    60. Generation of a monoclonal antibody against the glycosylphosphatidylinositol-linked protein Rae-1 using genetically engineered tumor cells. Biological Procedures Online. 16.
    BOVER's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (347)
    Explore
    _
    Co-Authors (38)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _